We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 13.18%
3 Financials 12.45%
4 Consumer Discretionary 10.8%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIQT icon
4126
LiqTech
LIQT
$19.7M
$77K ﹤0.01%
1,312
MITT
4127
TPG Mortgage Investment Trust
MITT
$214M
$77K ﹤0.01%
6,013
AAIC
4128
DELISTED
Arlington Asset Investment Corp.
AAIC
$77K ﹤0.01%
18,961
-105,737
-85% -$429K
MLSS icon
4129
Milestone Scientific
MLSS
$48.6M
$76K ﹤0.01%
30,954
-97,831
-76% -$237K
NUWE icon
4130
Nuwellis
NUWE
$485K
0
PVLA
4131
Palvella Therapeutics
PVLA
$2.24B
$76K ﹤0.01%
246
-1,300
-84% -$285K
LUB
4132
DELISTED
Luby's Inc.
LUB
$76K ﹤0.01%
19,751
AREC icon
4133
American Resources Corp
AREC
$296M
$75K ﹤0.01%
29,255
-5,333
-15% -$16.1K
GALT icon
4134
Galectin Therapeutics
GALT
$346M
$74K ﹤0.01%
23,080
-76,821
-77% -$273K
INOD icon
4135
Innodata
INOD
$2.01B
$74K ﹤0.01%
10,573
VNRX icon
4136
VolitionRx Ltd
VNRX
$7.59M
$74K ﹤0.01%
1,118
-3,380
-75% -$229K
WORX
4137
DELISTED
SCWORX CORP NEW
WORX
$74K ﹤0.01%
190
-34
-15% -$12.7K
CNCE
4138
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$74K ﹤0.01%
17,640
-89,549
-84% -$379K
SOGP
4139
Sound Group
SOGP
$49M
$73K ﹤0.01%
+1,000
New +$64K
CNVS icon
4140
Cineverse
CNVS
$69.2M
$72K ﹤0.01%
+2,801
New +$77.3K
PHLT
4141
DELISTED
Performant Healthcare Inc
PHLT
$72K ﹤0.01%
19,112
-2,072
-10% -$5.89K
CFRX
4142
DELISTED
ContraFect Corporation
CFRX
$72K ﹤0.01%
204
-615
-75% -$201K
HYMC icon
4143
Hycroft Mining Holding Corp
HYMC
$2.48B
$71K ﹤0.01%
2,322
NERV icon
4144
Minerva Neurosciences
NERV
$190M
$71K ﹤0.01%
3,845
-11,199
-74% -$241K
APRN
4145
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$71K ﹤0.01%
1,382
-1,641
-54% -$104K
GNPX icon
4146
Genprex
GNPX
$2.54M
-2
Closed -$328K
XCUR icon
4147
Exicure
XCUR
$8.54M
$70K ﹤0.01%
310
-859
-73% -$225K
PPIH
4148
Perma-Pipe International
PPIH
$217M
$69K ﹤0.01%
10,356
AGRX
4149
DELISTED
Agile Therapeutics
AGRX
$69K ﹤0.01%
26
-72
-73% -$237K
BKTI icon
4150
BK Technologies
BKTI
$280M
$67K ﹤0.01%
4,272

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.